These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8043483)
21. Viral hepatitis in Bucharest. Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496 [TBL] [Abstract][Full Text] [Related]
22. [The epidemiological aspects and prevalence of markers in those with viral hepatitis C in some population categories in 1994-1997 in Iaşi County]. Ivan A; Azoicăi D; Filimon R; Scripcaru L; Stefanache F; Luca V; Scripcariu D; Chiriac L; Iacob E; Calangiu E Bacteriol Virusol Parazitol Epidemiol; 1998; 43(4):275-9. PubMed ID: 10422324 [TBL] [Abstract][Full Text] [Related]
23. The seroprevalence of hepatitis C virus infection among blood donors from the North West region of Romania. Brumboiu IM; Czernichow P; Hâţu G; Gorgan IN; Hosu O; Bocşan IS Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):465-75. PubMed ID: 24340532 [TBL] [Abstract][Full Text] [Related]
24. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of hepatitis C virus infection in children admitted to an urban hospital. Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics. Bhattacharya DK; Bhattacharjee S; De M; Lahiri P Indian J Med Res; 1991 Dec; 94():430-2. PubMed ID: 1774095 [TBL] [Abstract][Full Text] [Related]
28. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China). Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374 [No Abstract] [Full Text] [Related]
29. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. Jamal R; Fadzillah G; Zulkifli SZ; Yasmin M Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):792-4. PubMed ID: 10772566 [TBL] [Abstract][Full Text] [Related]
30. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria. Erhabor O; Ejele OA; Nwauche CA Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284 [TBL] [Abstract][Full Text] [Related]
31. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region]. Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343 [TBL] [Abstract][Full Text] [Related]
32. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003]. Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M; Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421 [TBL] [Abstract][Full Text] [Related]
33. Antibodies to hepatitis C virus in thalassemia. Angelucci E Haematologica; 1994; 79(4):353-5. PubMed ID: 7528705 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus seroprevalence rate among Saudis. Shobokshi OA; Serebour FE; Al-Drees AZ; Mitwalli AH; Qahtani A; Skakni LI Saudi Med J; 2003 Jul; 24 Suppl 2():S81-6. PubMed ID: 12897907 [TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal. Karki S; Ghimire P; Tiwari BR; Shrestha AC; Gautam A; Rajkarnikar M Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):66-70. PubMed ID: 19323036 [TBL] [Abstract][Full Text] [Related]
36. [Antibodies against hepatitis C virus. Study in voluntary blood donors. Cuba 1991]. Galban García E; Padrón G; Arus Soler E; González O; Rodríguez Z; Mora S; Brito M G E N; 1992; 46(1):10-4. PubMed ID: 1339033 [TBL] [Abstract][Full Text] [Related]
37. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand. Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992 [TBL] [Abstract][Full Text] [Related]
38. Estimated risk of transmission of hepatitis C virus by blood transfusion. Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400 [TBL] [Abstract][Full Text] [Related]
39. The prevalence of hepatitis C virus antibodies among high risk groups in Thailand. Poovorawan Y; Pongpunlert W; Chumdermpadetsuk S; Sakulramrung R; Israsena S Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):133-4. PubMed ID: 1658945 [No Abstract] [Full Text] [Related]
40. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis. Nakayama E; Liu JH; Akiba T; Marumo F; Sato C J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]